Preoperative dual antiplatelet therapy and early outcomes in patients undergoing coronary artery bypass grafting

1 September 2019 (14:44 - 14:58)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Jianyu Qu

Fuwai Hospital, CAMS and PUMC, Beijing (China)

4 More presentations in this session

Presentation thumbnail

Effect of ticagrelor plus aspirin, ticagrelor alone, or aspirin alone on vein-graft patency 1 year after coronary artery bypass grafting with or without diabetes: a post-hoc analysis of the DACAB tria

Doctor Y. Zhu (Shanghai, CN)

Abstract Slides Video

Presentation thumbnail

"New-onset atrial fibrillation efter cardiac surgery is associated with increased long-term morbidity and mortality": a population-based study from the SWEDEHEART-registry.

Doctor A. Taha (Gothenburg, SE)

Abstract Slides Video

Presentation thumbnail

The randomised study of epicardial application of hydrogel with amiodarone for prevention of postoperative atrial fibrillation in patients after coronary artery bypass grafting

Doctor T. Kanametov (Moscow, RU)

Abstract Slides Video

Presentation thumbnail

Limited impact of concomitant coronary artery by-pass grafting on long-term outcomes after surgical aortic valve replacement: a nationwide propensity matched study

Doctor V. Kyto (Turku, FI)

Abstract Slides Video

Access the full session

Session thumbnail

Factors affecting prognosis of CABG patients

The Event

ESC Congress 2019

1 September 2019 14:44 CET

You may be interested in

Congress Presentation

2024 ESC Guidelines on Chronic Coronary Syndromes: case presentation

Congress Presentation

Percutaneous coronary revascularisation in adult congenital heart disease

Congress Presentation

Abnormal origination of all coronary arteries from the right sinus of Valsalva

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources